Literature DB >> 3578785

A sensitive, nonradiometric assay for dihydroorotic acid dehydrogenase using anion-exchange high-performance liquid chromatography.

G J Peters, E Laurensse, A Leyva, H M Pinedo.   

Abstract

A new method to assay the mitochondrial pyrimidine de novo enzyme, dihydroorotate (DHO) dehydrogenase, which catalyzes the dehydrogenation of DHO, with orotic acid as the product was developed. The assay was optimized using a rat liver mitochondrial preparation. Orotic acid was quantified with high-performance liquid chromatography using an anion-exchange column (Partisil-SAX) with uv detection at 280 nm. Isocratic elution with low phosphate buffer at pH 4.0 was used. The detection limit was 20 pmol per injection, which is comparable to previously described radiometric assays. The HPLC assay was compared with a spectrophotometric assay measuring orotic acid formation in a deproteinized reaction mixture. Absorbance was measured at the optimal wavelength for orotic acid, 278.5 nm. This assay is less sensitive and less specific than the HPLC assay, which can also detect UMP which might be formed from orotic acid in whole homogenates. With both assays kinetic parameters of the enzyme were determined. In the high concentration range (80-1000 microM) both Km and Vmax values were comparable. With the HPLC assay the concentration range was extended down to 12 microM and initial rates could be determined. The apparent Km was about 12 microM. The HPLC assay is also suitable for use in the study of inhibition of DHO dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3578785     DOI: 10.1016/0003-2697(87)90647-6

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390).

Authors:  G J Peters; S L Sharma; E Laurensse; H M Pinedo
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

2.  Dihydroorotate dehydrogenase is required for N-(4-hydroxyphenyl)retinamide-induced reactive oxygen species production and apoptosis.

Authors:  Numsen Hail; Ping Chen; Jadwiga J Kepa; Lane R Bushman; Colin Shearn
Journal:  Free Radic Biol Med       Date:  2010-04-24       Impact factor: 7.376

Review 3.  Brequinar sodium.

Authors:  D V Cramer
Journal:  Pediatr Nephrol       Date:  1995       Impact factor: 3.714

4.  Accumulation of Pyrimidine Intermediate Orotate Decreases Virulence Factor Production in Pseudomonas aeruginosa.

Authors:  Abdurahman Niazy; Lee E Hughes
Journal:  Curr Microbiol       Date:  2015-04-28       Impact factor: 2.188

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.